诚意药业 (603811)
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 32730.43
- Circulating A-Shares(W): 32730.43
- Earnings Per Share(RMB): 0.4500
- Net Assets Per Share(RMB): 4.0391
- Operating Revenue(W RMB): 59703.10
- Total Profit(W RMB): 16387.26
- **Net Profit Attributable to Parent(W RMB) **: 14272.35
- Net Profit Growth Rate(%): 21.91
- Weighted Return on Equity(%): 10.9900
- Operating Cash Flow Per Share(RMB): 0.6020
- Undistributed Profit Per Share(RMB): 2.3885
- Capital Reserve Per Share(RMB): 0.3747
2. Main Business
The main business covers:
- Research, production, and sales of chemical drug APIs and formulations
3. Company Basic Information
- Company Name: Zhejiang Chengyi Pharmaceutical Co., Ltd.
- Listing Date: 2017-03-15
- Industry: Pharmaceutical Manufacturing
- Address: No. 118 Huagong Road, Dongtou District, Wenzhou City, Zhejiang Province
- Website: https://www.chengyipharma.com
- Company Profile: The company was established through the overall transformation of Zhejiang Chengyi Pharmaceutical Co., Ltd. On February 22, 2013, the shareholders' meeting of Zhejiang Chengyi Pharmaceutical Co., Ltd. passed a resolution to transform the company into a joint stock company, based on the audited net assets as of December 31, 2012.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhejiang Chengyi Pharmaceutical Co., Ltd. - 2025 Employee Stock Ownership Plan | Asset Management Plan | 961.88 | 2.94 |
| 2 | National Social Security Fund 604 Portfolio | Social Security Fund | 473.38 | 1.45 |
| 3 | Wenzhou Dongtou District Chengyi Microfinance Co., Ltd. | General Legal Person | 352.59 | 1.08 |
5. Concept Sectors
- Vitamins
- Hepatitis Concept
- Proposed Reduction
- Micro-cap Selection
- Special Loans
- Micro and Small Cap Stocks
- CSI Buyback
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information